Targeting eIF4A Dependent Translation of KRAS Signaling Molecules.
Cancer Res 2021 Feb 25:canres.2929.2020 [online ahead of print]
Pancreatic adenocarcinoma (PDAC) epitomizes a deadly cancer driven by abnormal KRAS signalling. Here we show that the eIF4A RNA helicase is required for translation of key KRAS signaling molecules and that pharmacological inhibition of eIF4A has single-agent activity against murine and human PDAC models at safe dose levels. EIF4A was uniquely required for the translation of mRNAs with long and highly structured 5'UTRs including those with multiple G-quadruplex (GQ) elements. Computational analyses identified these features in mRNAs encoding KRAS and key downstream molecules. Transcriptome-scale ribosome footprinting accurately identified eIF4A-dependent mRNAs in PDAC including critical KRAS signaling molecules such as PI3K, RALA, RAC2, MET, MYC, and YAP1. These findings contrast with a recent study that relied on an older method, polysome fractionation, and implicated redox-related genes as eIF4A clients. Together, our findings highlight the power of ribosome footprinting in conjunction with deep RNA sequencing in accurately decoding translational control mechanisms and define the therapeutic mechanism of eIF4A inhibitors in PDAC.
Singh, Kamini; Lin, Jianan; Lecomte, Nicolas; Mohan, Prathibha; Gokce, Askan; Sanghvi, Viraj R; Jiang, Man; Grbovic-Huezo, Olivera; Burčul, Antonija; Stark, Stefan G; Romesser, Paul B; Chang, Qing; Melchor, Jerry P; Beyer, Rachel K; Duggan, Mark; Fukase, Yoshiyuki; Yang, Guangli; Ouerfelli, Ouathek; Viale, Agnes; de Stanchina, Elisa; Stamford, Andrew W; Meinke, Peter T; Rätsch, Gunnar; Leach, Steven D; Ouyang, Zhengqing; and Wendel, Hans-Guido, "Targeting eIF4A Dependent Translation of KRAS Signaling Molecules." (2021). Faculty Research Ahead of Print. 270.